journal article·2020-11-30Open access

Tetragonia tetragonoides (Pall.) Kuntze Restores Blood Perfusion from Hind-Limb Ischemic Mice

Hyun Yang, Dong Ho Jung, Hye Won Lee, Dongoh Lee, Byoung Seob Ko

Applied Sciences· Volume 10· Issue 23

Abstract

Tetragonia tetragonoides (Pall.) Kuntze (TTK) is grown for the edible leaves, and can be used as food. And which commonly called Beonhaengcho in Republic of Korea. TTK is found along the seaside of the Jeju-Island and it has long been consumed as a food for women’s health. We investigated the effects of TTK on peripheral circulation disorder during menopausal transition and/or menopause in a hind-limb ischemic (HLI) mouse model. Chemotactic motility and tube formation of vascular epithelial cells were evaluated in human umbilical vein endothelial cells (HUVECs). Female C57BL/6 mice were fed a TTK (150 or 450 mg/kg/day) for four weeks and the rate of blood flow was assessed using a laser Doppler after HLI. TTK treatment significantly increased cell migration and the branch interval value of tubular structure in a dose-dependently. In the TTK treatment group, blood flow rate was significant induced at 7, 14, and 28 days after HLI, compared with the vehicle. TTK treatment also an increase in capillary density, and the highest levels of pERK(1/2), pAkt, pPLCγ1 and pFAK proteins compared to the vehicle control. These results suggest that extract of TTK may ameliorate the blood flow via improvement of peripheral angiogenesis under hind-limb ischemic stress in a menopausal mouse model.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · Menopause: Health Impacts and Treatments · Botanical Studies and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Korea

Funding

Korea Institute of Oriental Medicine

References (60)

Show source-provided references
1. The complex role of estrogens in inflammation10.1210/er.2007-0001 ↗
2. Menopause and sexuality: Prevalence of symptoms and impact on quality of life10.1016/j.maturitas.2009.03.021 ↗
3. Hypertension, menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study10.1016/j.jacc.2005.02.099 ↗
4. Estrogen levels in postmenopausal women with hot flashes
5. Estrogen deficiency and bone loss: An inflammatory tale10.1172/JCI28550 ↗
6. Estrogen and coronary heart disease in women10.1001/jama.1991.03460140089033 ↗
7. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women10.1161/01.CIR.93.10.1928 ↗
8. Critical Limb Ischemia: Nothing to Give at the Office?10.7326/0003-4819-130-5-199903020-00017 ↗
9. Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease10.1177/1358863X14552013 ↗
10. Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease10.1016/j.jvs.2011.02.057 ↗
11. Heart disease and stroke statistics—2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
12. The link between osteoporosis and cardiovascular disease
13. Oestrogens and the heart
14. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease10.7326/0003-4819-133-12-200012190-00008 ↗
15. Cardiovascular aspects of menopausal hormone replacement therapy10.1080/13697130903012306 ↗
16. Estrogen, hormonal replacement therapy and cardiovascular disease10.1097/MNH.0b013e3283431921 ↗
17. Estrogen plus Progestin and the Risk of Coronary Heart Disease10.1056/NEJMoa030808 ↗
18. Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women10.1001/jama.280.7.605 ↗
19. Cardiovascular Disease Outcomes during 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)—Correction10.1001/jama.288.1.58 ↗
20. Cardiovascular disease in women10.1161/01.CIR.88.4.1999 ↗
21. Phytoestrogens in postmenopausal indications: A theoretical perspective10.4103/0973-7847.79098 ↗
22. Estrogen and stroke: A balanced analysis10.1161/01.STR.0000054051.88378.25 ↗
23. Estrogen stimulates angiogenesis in normoperfused skeletal muscle in rabbits10.1161/01.CIR.103.21.e107 ↗
24. Estrogen and angiogenesis: A review10.1161/01.ATV.21.1.6 ↗
25. 17beta-estradiol inhibits apoptosis of endothelial cells10.1006/bbrc.1997.7085 ↗
26. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response10.1016/S0002-9440(10)65217-0 ↗
27. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen10.1172/JCI5347 ↗
28. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 210.1677/JOE-07-0292 ↗
29. Expression of estrogen receptors-alpha and -beta in the pregnant ovine uterine artery endothelial cells in vivo and in vitro10.1095/biolreprod.104.035949 ↗
30. Estrogen enhances wound healing in the penis of rats10.2220/biomedres.29.267 ↗
31. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor10.1172/JCI16288 ↗
32. Estrogen receptors and human disease10.1172/JCI27987 ↗
33. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia10.1177/1358863X08096666 ↗
34. Ahn, S., Lee, S., Kim, N., Park, H., Kim, P.H., Kwon, O., and Ahn, S. (2008). Donguibogam (English Version), Korean Institute of Oriental Medicine.
35. Tetragonia tetragonioides (Pall.) Kuntze protects estrogen-deficient rats against disturbances of energy and glucose metabolism and decreases proinflammatory cytokines10.1177/1535370216683835 ↗
36. Comparison of ovarian and hypothalamic obesity syndromes in the female rat: Effects of diet palatability on food intake and body weight10.1037/h0077328 ↗
37. Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown10.1016/j.jsbmb.2014.01.016 ↗
38. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms10.1097/00042192-200203000-00010 ↗
39. Adverse interactions between herbal and dietary substances and prescription medications: A clinical survey
40. Medicinal plants: Traditions of yesterday and drugs of tomorrow10.1016/j.mam.2005.07.008 ↗
41. Endocrine modulators in the food chain and environment10.1177/019262330002800311 ↗
42. Risks and benefits of commonly used herbal medicines in Mexico10.1016/j.taap.2007.10.005 ↗
43. Measurement depth and volume in laser Doppler flowmetry10.1016/j.mvr.2009.02.008 ↗
44. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
45. In vivo imaging of the molecular distribution of the VEGF receptor during angiogenesis in a mouse model of ischemia10.1182/blood-2010-12-322842 ↗
46. Lobo, R.A. (1997). Serono Symposia USA: Perimenopause, Springer.10.1007/978-1-4612-2288-0 ↗
47. Novi, J.M., and Ross, H.L. (2009). Perimenopause, Informa Healthcare.10.3109/9781420014365 ↗
48. Estrogen deficiency attenuates neovascularization in a murine model of hindlimb ischemia10.1016/j.jss.2012.04.067 ↗
49. Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: Role of endothelial cell nitric oxide synthase10.1073/pnas.0235680100 ↗
50. Estrogen Accelerates Cutaneous Wound Healing by Promoting Proliferation of Epidermal Keratinocytes via Erk/Akt Signaling Pathway10.1159/000443048 ↗
51. Estrogen Receptor-α, Sexual Dimorphism and Reduced-Size Liver Ischemia and Reperfusion Injury in Mice10.1203/01.PDR.0000110524.88784.DD ↗
52. Effect of estradiol, progesterone and testosterone on apoptosis- and proliferation-induced MAPK signaling in human umbilical vein endothelial cells
53. Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells10.3892/mmr.2012.753 ↗
54. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways during Brain Ischemia/Reperfusion10.1177/1759091415602463 ↗
55. Activation of ERK accelerates repair of renal tubular epithelial cells, where as it inhibits progression of fibrosis following ischemia/reperfusion injury10.1016/j.bbadis.2013.07.001 ↗
56. Endothelial FAK is required for tumour angiogenesis10.1002/emmm.201000106 ↗
57. Protein tyrosine kinase structure and function10.1146/annurev.biochem.69.1.373 ↗
58. Akt binds to and phosphorylates phospholipase C-gamma1 in response to epidermal growth factor10.1091/mbc.e05-10-0918 ↗
59. Vascular endothelial growth factor (VEGF) and its receptors
60. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells10.1091/mbc.e02-09-0621 ↗